Management of diabetic neuropathy

Malaysian Journal of Medical Sciences

Volumn 10, Issue 2, 2003, Pages 27-30

  Ali, Raymond Azman ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Diabetes Mellitus; Management; Neuropathy

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; ANTIOXIDANT; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; ERYTHROMYCIN; ESSENTIAL FATTY ACID; FLUDROCORTISONE; GABAPENTIN; GLUCOSE; IBUPROFEN; IMMUNOGLOBULIN; INOSITOL; INSULIN; METOCLOPRAMIDE; MEXILETINE; MIDODRINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENYLPROPANOLAMINE; RECOMBINANT NERVE GROWTH FACTOR; SILDENAFIL; TETRACYCLINE; VASODILATOR AGENT;

ANALGESIA; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; DIARRHEA; DISEASE SEVERITY; ERECTILE DYSFUNCTION; GASTROINTESTINAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTEGUMENT; NEUROGENIC BLADDER; ORTHOSTATIC HYPOTENSION; PATHOGENESIS; RADICULOPATHY; REVIEW; SKIN CARE; SKIN DISEASE; TREATMENT PLANNING; UROGENITAL TRACT DISEASE;

EID: 2642550609     PISSN: 1394195X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurgery Psychiatry 1997; 62: 310-8.
2. Bosch EP, Smith BE. Disorders of the Peripheral Nerve. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, eds. Neurology in Clinical Practice Third Edition. Oxford: Butterworth-Heinemann, 2000; 2045-130.
3. Thomas PK. Classification, differential diagnosis, and staging of diabetic neuropathy. Diabetes 1997; 46 Suppl, 2: S54-S57.
4. Anand P. Neurotrophins and peripheral neuropathy. Phil Trans R Soc London 1996; 351: 449-54.
5. Dyck PJ, Giannini C. Pathologic, alterations in the diabetic neuropathies of humans: a review. J Neuropathol Exp Neurol 1997; 55: 1181-93.
6. Diabetes Control and Complication Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561-8.
7. Krendel DA, Costigan DA, Hopkins LC. Successful treatment of neuropathies in patients with diabetes mellitus. Arch Neurol 1995; 52: 1063-61.
8. Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs. placebo in neurogenic orthostatic hypotension. A randomised, double-blind multicenter study. Midodrine: study group. JAMA 1997; 277: 1046-51.
9. Apfel SC, Kessler JA, Adornato BT, et al. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 1998; 51: 695-702.
10. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997; 46 Suppl 2: S62-S66.
11. Nelson KA, Park KM, Roinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997: 48: 1212-8.
12. Horrobin DF. Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes 1997; 46 Suppl 2: S90-S93.